Home
Search:
1146 feeds
357 categories
3690 articles (<24 hours)
25 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve


RSS FeedsAstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients
(WorldNews Business)

 
 

4 july 2020 17:16:29

 
AstraZeneca#39;s Dapagliflozin gets DCGI nod for treatment of heart failure patients
(WorldNews Business)
 


The company has received import and market permission from DCGI in Form CT-20 (Marketing Authorisation- Additional Indication). PTI Trade Watchlist Portfolio Message Set Alert live bselivenselive Volume Todays L/H More × Drug firm AstraZeneca Pharma India on Saturday said it has received approval from Drugs Controller General of India (DCGI) for Dapagliflozin tablets for treatment of patients suffering from heart failure with reduced ejection fraction. The company has received import and market permission...


 
18 viewsCategory: Business
 
ERC slashes WESM market fees
(WorldNews Business)
Trump`s `strong wall` to block COVID-19 from China had holes
(WorldNews Business)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten